Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Gleim

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Plos One|July 11, 2013
Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysisScott Gleim, Jeremiah Stitham, Wai Ho Tang, et al.
Circulation|January 30, 2014
Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic plateletsWai Ho Tang, Jeremiah Stitham, Yu Jin, et al.
Circulation|December 10, 2017
Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial InfarctionsJaison Jacob, Debby Ngo, Nancy Finkel, et al.
The Journal of Clinical Investigation|October 19, 2011
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxaneWai Ho Tang, Jeremiah Stitham, Scott Gleim, et al.
Scientific Reports|November 19, 2020
Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screenLina Schukur, Tamara Zimmermann, Ole Niewoehner, et al.
Pharmacogenetics and Genomics|June 14, 2008
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker studyPaola Patrignani, Concetta Di Febbo, Stefania Tacconelli, et al.
The Journal of Clinical Investigation|November 14, 2017
Recurrent ubiquitin B silencing in gynecological cancers establishes dependence on ubiquitin CAlexia T Kedves, Scott Gleim, Xiaoyou Liang, et al.
Cell Chemical Biology|September 9, 2021
A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probesBenika J Pinch, Dennis L Buckley, Scott Gleim, et al.
Circulation Research|March 8, 2008
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibitionEric Arehart, Jeremiah Stitham, Folkert W Asselbergs, et al.
Science Signaling|May 14, 2015
Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibitionYi Xie, Yu Jin, Bethany L Merenick, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Plos One|July 11, 2013
Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysisScott Gleim, Jeremiah Stitham, Wai Ho Tang, et al.
Circulation|January 30, 2014
Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic plateletsWai Ho Tang, Jeremiah Stitham, Yu Jin, et al.
Circulation|December 10, 2017
Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial InfarctionsJaison Jacob, Debby Ngo, Nancy Finkel, et al.
The Journal of Clinical Investigation|October 19, 2011
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxaneWai Ho Tang, Jeremiah Stitham, Scott Gleim, et al.
Scientific Reports|November 19, 2020
Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screenLina Schukur, Tamara Zimmermann, Ole Niewoehner, et al.
Pharmacogenetics and Genomics|June 14, 2008
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker studyPaola Patrignani, Concetta Di Febbo, Stefania Tacconelli, et al.
The Journal of Clinical Investigation|November 14, 2017
Recurrent ubiquitin B silencing in gynecological cancers establishes dependence on ubiquitin CAlexia T Kedves, Scott Gleim, Xiaoyou Liang, et al.
Cell Chemical Biology|September 9, 2021
A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probesBenika J Pinch, Dennis L Buckley, Scott Gleim, et al.
Circulation Research|March 8, 2008
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibitionEric Arehart, Jeremiah Stitham, Folkert W Asselbergs, et al.
Science Signaling|May 14, 2015
Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibitionYi Xie, Yu Jin, Bethany L Merenick, et al.
Pageof 3